Rafael Bayarri Olmos, PhD
Associate Research ScientistDownloadHi-Res Photo
Cards
Contact Info
About
Copy Link
Titles
Associate Research Scientist
Education & Training
- PhD
- Copenhagen University, Faculty of Health and Medical Sciences, PhD degree in Molecular Immunology (2018)
- MSc
- Copenhagen University, Faculty of Science, Master's degree in Biotechnology (2013)
- BSc
- University of Leon, Faculty of Biology and Biotechnology, 5-year degree in Biotechnology (2011)
Research
Copy Link
Overview
Public Health Interests
Emerging Infectious Diseases; Immunology; Respiratory Disease/Infections; Vaccines; Viruses; Pharmaceuticals and Medical Devices; COVID-19
ORCID
0000-0003-3202-9679- View Lab Website
Iwasaki lab
Research at a Glance
Yale Co-Authors
Frequent collaborators of Rafael Bayarri Olmos's published research.
Publications Timeline
A big-picture view of Rafael Bayarri Olmos's research output by year.
Akiko Iwasaki, PhD
Andrew J. Hudak
Charalampia Koutsioumpa, MD, PhD
Christopher A Baker, PhD
Claire S. Laxton, PhD
Dong-il Kwon
38Publications
1,762Citations
Publications
2026
Bioactive enhanced adjuvant chemokine oligonucleotide nanoparticles (BEACONs) for mucosal vaccination against genital herpes.
Bhagchandani SH, Ehrenzeller S, Pires IS, Chaudhary N, Booth CJ, Kwon DI, Koutsioumpa C, Baker CA, Laxton C, Santos Guedes de Sá K, Matthews C, Gill P, Li S, Olszowka A, Hudak A, Fischer S, Bayarri-Olmos R, Hooper WB, Iwasaki A. Bioactive enhanced adjuvant chemokine oligonucleotide nanoparticles (BEACONs) for mucosal vaccination against genital herpes. Sci Immunol 2026, 11: eaea6419. PMID: 42319912, DOI: 10.1126/sciimmunol.aea6419.Peer-Reviewed Original ResearchThis study investigates a novel vaccine strategy using BEACONs, a mucosal adjuvant, to enhance localized immunity and protect against genital herpes by boosting tissue-resident T cells and antibodies.
2023
Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody
Cyranka L, Mariegaard I, Skjødt M, Bayarri-Olmos R, Mollnes T, Garred P, Rosbjerg A. Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody. Journal Of Innate Immunity 2023, 15: 836-849. PMID: 37952515, PMCID: PMC10691831, DOI: 10.1159/000535084.Peer-Reviewed Original ResearchCitationsAltmetricDiverging humoral and cellular immune responses due to Omicron—a national study from the Faroe Islands
Petersen M, Pérez-Alós L, Kongsstovu S, Eliasen E, Hansen C, Larsen S, Hansen J, Bayarri-Olmos R, Fjallsbak J, Weihe P, Garred P. Diverging humoral and cellular immune responses due to Omicron—a national study from the Faroe Islands. Microbiology Spectrum 2023, 11: e00865-23. PMID: 37909772, PMCID: PMC10714973, DOI: 10.1128/spectrum.00865-23.Peer-Reviewed Original ResearchCitationsAltmetricMAP‐2:CD55 chimeric construct effectively modulates complement activation
González‐del‐Barrio L, Pérez‐Alós L, Cyranka L, Rosbjerg A, Nagy S, Prohászka Z, Garred P, Bayarri‐Olmos R. MAP‐2:CD55 chimeric construct effectively modulates complement activation. The FASEB Journal 2023, 37: e23256. PMID: 37823685, DOI: 10.1096/fj.202300571r.Peer-Reviewed Original ResearchCitationsAltmetricDistinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodies
Jarlhelt I, Pérez-Alós L, Bayarri-Olmos R, Hansen C, Petersen M, Weihe P, Armenteros J, Madsen J, Nielsen J, Hilsted L, Iversen K, Bundgaard H, Nielsen S, Garred P. Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodies. Microbiology Spectrum 2023, 11: e01796-23. PMID: 37738355, PMCID: PMC10580960, DOI: 10.1128/spectrum.01796-23.Peer-Reviewed Original ResearchCitationsAltmetricPrevious immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
Pérez-Alós L, Hansen C, Almagro Armenteros J, Madsen J, Heftdal L, Hasselbalch R, Pries-Heje M, Bayarri-Olmos R, Jarlhelt I, Hamm S, Møller D, Sørensen E, Ostrowski S, Frikke-Schmidt R, Hilsted L, Bundgaard H, Nielsen S, Iversen K, Garred P. Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk. Nature Communications 2023, 14: 5624. PMID: 37699890, PMCID: PMC10497567, DOI: 10.1038/s41467-023-41342-2.Peer-Reviewed Original ResearchCitationsAltmetricRevaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patients.
Ammitzbøll C, Thomsen M, Andersen J, Jensen J, Bayarri-Olmos R, Garred P, Hermansen M, Johannsen A, Larsen M, Mistegaard C, Mikkelsen S, Nielsen L, Olesen R, Pérez-Alós L, Vils S, Szabados F, Søgaard O, Tolstrup M, Erikstrup C, Hauge E, Troldborg A. Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patients. Clinical And Experimental Rheumatology 2023, 42: 157-165. PMID: 37877429, DOI: 10.55563/clinexprheumatol/orpp04.Peer-Reviewed Original ResearchCitationsShort-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination
Madsen J, Holm B, Pérez-Alós L, Bayarri-Olmos R, Rosbjerg A, Fogh K, Pries-Heje M, Møller D, Hansen C, Heftdal L, Hasselbalch R, Hamm S, Frikke-Schmidt R, Hilsted L, Nielsen S, Iversen K, Bundgaard H, Garred P. Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination. Microbiology Spectrum 2023, 11: e04947-22. PMID: 36877077, PMCID: PMC10101069, DOI: 10.1128/spectrum.04947-22.Peer-Reviewed Original ResearchCitationsAltmetric
2022
Enzyme-Linked Immunosorbent Assay for Activation of the Classical Complement Pathway by Plasmodium falciparum-Infected Erythrocyte Surface Antigen-Specific Antibodies
Larsen M, Bayarri-Olmos R, Garred P, Hviid L. Enzyme-Linked Immunosorbent Assay for Activation of the Classical Complement Pathway by Plasmodium falciparum-Infected Erythrocyte Surface Antigen-Specific Antibodies. Methods In Molecular Biology 2022, 2470: 673-678. PMID: 35881382, DOI: 10.1007/978-1-0716-2189-9_50.ChaptersCitationsAltmetricLectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19
Götz M, Skjoedt M, Bayarri-Olmos R, Hansen C, Pérez-Alós L, Jarlhelt I, Benfield T, Rosbjerg A, Garred P. Lectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19. Journal Of Innate Immunity 2022, 15: 122-135. PMID: 35816998, PMCID: PMC10643890, DOI: 10.1159/000525508.Peer-Reviewed Original ResearchCitationsAltmetric
Get In Touch
Copy Link